We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blood Transfer Devices Assessed for Malaria Test

By LabMedica International staff writers
Posted on 16 Feb 2011
A comparison has been made of different devices for transferring blood to the rapid diagnostic test (RDT) for malaria in three developing countries. More...


The five blood transfer devices evaluated were the loop and inverted cup, made of hard plastic; a straw-pipette and calibrated pipette, made of soft plastic, and a glass capillary tube.

A study was conducted between August and November 2009 among 227 health workers in Nigeria, the Philippines, and Uganda, under the auspices of the Foundation for Innovative New Diagnostics, (FIND; Geneva, Switzerland). The participants were recruited from the staff of frontline health centers and community-based malaria programs. The devices were evaluated for accuracy, safety, and ease of use. The participating health workers used each device to transfer blood from a simulated finger prick site to filter paper. Blood volume transferred was calculated from the area of blood spots deposited on filter paper.

The overall mean volumes transferred by devices differed significantly from the target volume of 5 μL which is the minimum amount recommended for the most RDTs. The new inverted cup device transferred a mean of 4.6 μL, which most closely approximated the target volume. The glass capillary was excluded from volume analysis, as the estimation method used is not compatible with this device. The calibrated pipette accounted for the largest proportion of blood exposures to 10% of the health worker. Blood exposures for the other four devices ranged from 2% to 6%. According to 91% of the health workers, the inverted cup was considered easiest to use in blood collection, while the straw-pipette and calibrated pipette were rated the most difficult to use.

Rapid diagnostic tests are becoming the standard method of detection of malaria in poor resource settings. The blood transfer device is an essential part of the kit because the sensitivity of the tests is compromised when an inadequate volume is transferred to the RDT cassette, especially when parasite density falls below 200 parasite/μL. The findings of this study have relevance for any point-of-care diagnostics that require blood sampling. The variability in device performance demonstrated the need to devote attention to this issue when implementing RDT-based diagnostic programs. The study was published online on February 8, 2011, in the Malaria Journal.

Related Links:

Foundation for Innovative New Diagnostics






Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.